Hallucinations, air pollution risks top March retina news
The pandemic’s impact on visual hallucinations in people with impaired vision and increased risks for age-related macular degeneration from air pollution led March retina/vitreous coverage on Healio/OSN.
Read on for the best-performing pieces.
Q&A: Visual hallucinations may have worsened during pandemic
The COVID-19 pandemic may have exacerbated Charles Bonnet syndrome in some patients with low vision who experience visual hallucinations. Read more.
Q&A: Air pollution increases risk for AMD
Air pollution is a health hazard, and not only for the lungs. The eyes, and particularly the delicate layers of the retina, may be affected, and chronic exposure may trigger or speed up the mechanisms that lead to age-related degenerative eye diseases. Read more.
Anterior uveitis often associated with Zika virus infection
Anterior uveitis may be present in a high percentage of patients infected by Zika virus and is often associated with increased IOP. Read more.
Positive topline safety results reported for ONS-5010 in retinal disease treatment
Topline results from an open-label safety study investigating ONS-5010/Lytenava in the treatment of retinal diseases showed no unexpected safety results, according to a press release from Outlook Therapeutics. Read more.
VIDEO: Tyrosine kinase inhibitor implant performs well in phase 1 study for wet AMD
In this video, Andrew A. Moshfeghi, MD, MBA, discusses results from a phase 1 study of an intravitreal hydrogel axitinib implant for wet AMD he recently presented at the virtual Angiogenesis, Exudation, and Degeneration meeting. Watch here.